The greatest technical challenge facing the **gene editing market** today is not the editing tool itself, but the development of safe and efficient **delivery systems** capable of transporting the editing components to the target cells inside the human body (**in vivo**). An effective delivery system must protect the genetic cargo (the Cas enzyme and guide RNA), navigate the body’s...